Increased security in control procedures and risk management for the international trade of pharmaceuticals.

eXinvest of Emirates has implemented the first revision of its pharmaceutical procedures (01.2025), in alignment with European pharmacovigilance plans.

As of August 1, 2025, Revision 01.2025 of the Desk Audit Questionnaire for clients and suppliers will become operational.

In addition to the seven required sections — company profile, licenses, quality, warehousing, vendor management, shipping sites, and key persons — we have introduced on-site inspections and audits for new partners, even if located in countries that are logistically distant from our offices.

This has been made possible through an agreement with TÜV Bureau Certificate, a leading international verification and certification body with offices worldwide.

This represents a further investment aimed at upgrading eXinvest’s operational standards in pharmaceutical projects and ensuring maximum reliability for all our clients and suppliers.

The procedure is available upon request.

www.exinvest.ae
This email address is being protected from spambots. You need JavaScript enabled to view it.